Bill Nygren: The State of Value Investing Today
The Oakmark fund manager on the limits of macro, why financials look cheap, indexing’s pitfalls, and more.
Stay updated with breaking news from Applied Security Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Oakmark fund manager on the limits of macro, why financials look cheap, indexing’s pitfalls, and more.
Find the latest AptarGroup, Inc. (ATR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance
Find the latest Astrazeneca PLC (AZN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance
Summary Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States. Subscribe to Yahoo Finance Pl...
Madison Investments Portfolio Structure Provides Safe High Yield Returns February 4, 2021 Drew Justman, CFA, serves as a Portfolio Manager on Madison Investments’ covered call, dividend income and value strategies. He has been working in the financial services industry since 2001 and joined Madison in 2005. He earned his BBA in finance and economics and M.S. in finance from the University of Wisconsin-Madison, specializing in the Applied Security Analysis Program. Prior to joining Madison Investments, Mr. Justman worked at Merrill Lynch. In this 3,478 word interview, exclusively in the Wal...